Patents by Inventor Shu-Bin Lu

Shu-Bin Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral cisapride dosage forms with an extended duration
    Patent number: 6221396
    Abstract: The present invention provides sustained release oral solid dosage forms of cisapride by using a multi-particulate system, which are bioavailable and can provide efficient blood level of cisapride over 24 hours. Unit dosage forms of cisapride which comprise a plurality of substrates containing sustained release cisapride, as well as pharmaceutical compositions containing the dosage forms, are also disclosed herein.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: April 24, 2001
    Assignee: Development Center for Biotechnology
    Inventors: Shouchung Chao, Wen-Pao Tseng, Hui-Fang Chang, David Chen, Shu-Bin Lu
  • Controlled release tacrine dosage form
    Patent number: 6183777
    Abstract: Disclosed is a controlled release tacrine dosage form, which comprises: (a) a core; (b) an inner active layer comprising tacrine and a binder; (c) a release-controlling layer comprising one or more release-controlling-film-forming polymer; and (d) an active overcoat comprising tacrine and a binder. Also disclosed is a process for preparing the controlled release dosage form.
    Type: Grant
    Filed: January 14, 1998
    Date of Patent: February 6, 2001
    Assignee: Development Center for Biotechnology
    Inventors: Pao-Nien Chen, Chuan-Ming Lai, Shu-Jian Liu, Fan-Jung Liu, Shu-Bin Lu
  • Stabilization of prostaglandin drug
    Patent number: 5889051
    Abstract: A stable solid dispersion of prostaglandin drug, particularly Misoprostol, (.+-.)methyl 7-?3(.alpha.)-hydroxy-2-.beta.-(4 (RS)-4-hydroxy-4-methyl-trans-1-octen-1-yl)-oxycyclopent-1.alpha.-yl!hepta noate, comprising ammonio methacrylate copolymers. The ammonio methacrylate copolymers comprise Eudragit RS series, Eudragit RL series, Eudragit S, Eudragit L, and the mixture thereof. The stable solid dispersion is a sustained release type.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: March 30, 1999
    Assignee: Development Center for Biotechnology
    Inventors: David Chen, Rong-Jer Tsay, Hue-In Lin, Shu-Bin Lu